Chan Henry Lee, SVP, General Counsel at BeOne Medicines Ltd. (ONC), sold 20,230 shares at $350.00 ($7.1M) on 2025-10-08, disclosed to the SEC on 2025-10-10.
Scheduled sale ($7.1M) by SVP, General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $347.82 | 664 | $231K | 3.3% |
| 2 | $347.82 | 664 | $231K | 3.3% |
| 3 | $350.00 | 1,112 | $389K | 5.5% |
| 4 | $350.22 | 4,733 | $1.7M | 23.4% |
| 5 | $350.22 | 4,733 | $1.7M | 23.4% |
| 6 | $351.12 | 4,162 |
| $1.5M |
| 20.6% |
| 7 | $351.12 | 4,162 | $1.5M | 20.6% |
| Total | $350.42 avg | 20,230 | $7.1M | 100% |
| Filing → |
| ONC | SELL | 2026-08-03 | $338K | — | Filing → |
| ONC | SELL | 2026-07-24 | $542K | — | Filing → |
| ONC | SELL | 2026-07-10 | $201K | — | Filing → |